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Objectives. This study was undertaken to validate the in vivo
intravascular ultrasound (IVUS) measurement of in-stent neoin-
timal hyperplasia (IH) volumes.
Background. Because stents reduce restenosis compared to
balloon angioplasty, stent use has increased significantly. As a
result, in-stent restenosis is now an important clinical problem.
Serial IVUS studies have shown that in-stent restenosis is second-
ary to intimal hyperplasia. To evaluate strategies to reduce
in-stent restenosis, accurate measurement of in-stent neointimal
tissue is important.
Methods. Using a porcine coronary artery model of in-stent
restenosis, single Palmaz–Schatz stents were implanted into 16
animals with a stent:artery ratio of 1.3:1. Intravascular ultra-
sound imaging was performed at 1 month, immediately prior to
animal sacrifice. In vivo IVUS and ex vivo histomorphometric
measurements included stent, lumen and IH areas; IH volumes
were calculated with Simpson’s rule.
Results. Intravascular ultrasound measurements of IH (30.4 6
11.0 mm3) volumes correlated strongly with histomorphometric
measurements (26.7 6 8.5 mm3, r 5 0.965, p < 0.0001). The
difference between the IVUS and the histomorphometric measure-
ments of IVUS volume was 4.1 6 2.7 mm3 or 15.8 6 11% (standard
error of the estimate 5 0.7). Both histomophometry and IVUS
showed that IH was concentric and uniformly distributed over the
length of the stent. Intravascular ultrasound detected neointimal
thickening of <20.2 mm in 5 of 16 stents.
Sample size calculations based on the IVUS measurement of
IH volumes showed that 12 stented lesions/arm would be required
to show a 50% reduction in IVUS-measured IH volume and 44
stented lesions/arm would be required to show a 25% reduction in
IH volume.
Conclusions. In vivo IVUS measurement of IH volumes corre-
lated strongly with ex vivo histomorphometry. Using volumetric
IVUS end points, small sample sizes should be necessary to
demonstrate effectiveness of strategies to reduce in-stent resten-
osis.
(J Am Coll Cardiol 1998;32:794–9)
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Intracoronary stents reduce restenosis compared to balloon
angioplasty (1,2). Because stent use has increased significantly,
in-stent restenosis is now an important clinical problem. Serial
(postintervention and follow-up) intravascular ultrasound
(IVUS) studies have shown that in-stent restenosis is second-
ary to intimal hyperplasia (IH) (3,4). Thus, strategies to reduce
in-stent restenosis will succeed only by reducing in-stent neo-
intimal tissue accumulation; and accurate measurement of
in-stent neointimal tissue becomes important.
Intravascular ultrasound permits detailed, high quality,
cross-sectional imaging of the coronary arteries in vivo. The
normal coronary artery architecture, the major components of
the atherosclerotic plaque and the changes that occur during
atherogenesis, transcatheter therapy and follow-up can be
studied in a manner previously not possible. This includes the
direct visualization of the intensely echoreflective metallic
stent struts. The purpose of the current study was 1) to validate
IVUS measurements of neointimal tissue by histomorphom-
etry and 2) to estimate sample sizes needed to show significant
reduction in IVUS-measured in-stent neointimal tissue accu-
mulation.
Methods
Animal study protocol. This study was approved by the
Animal Care and Use Committee of the Medlantic Research
Institute and conformed to the tenets of the American Heart
Association on research animal use. Sixteen specific-pathogen-
free domestic pigs weighing 45 to 50 kg (Hidden Valley Farm,
Reisterstown, MD) were pretreated with oral aspirin 325 mg,
ticlopidine 250 mg and verapamil SR 120 mg 1 day before the
procedure. On the day of the procedure, the animals were
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anesthetized with intramuscular ketamine (20 mg/kg, Fort
Dodge Laboratories) and xylazine (2 mg/kg, Phoenix Pharma-
ceutical Inc., St. Joseph, MO) and intubated. Supplemental
oxygen (2 liters/min) was administered continuously via a
respirator, and sodium pentobarbital (10 mg/kg) was injected
intravenously as needed. Under sterile conditions, the left
carotid artery and external jugular vein were surgically exposed
and 8Fr and 6Fr sheaths, respectively, were inserted. Contin-
uous hemodynamic and surface electrocardiographic monitor-
ing was maintained throughout the procedure (Marquette
Electronics, Inc.). After systemic heparinization (300 U/kg
intravenously), control angiograms of the left coronary arteries
were performed with FL 3.5 guiding catheters (SciMed Life
Systems, Inc.) using nonionic contrast agent (Optiray 320,
Mallinckrodt Medical Inc., Maple Grove, MN) in two orthog-
onal views. A balloon catheter with one 15-mm Palmaz–Schatz
stent (Cordis A. Johnson and Johnson Company, Warren, NJ)
was placed in the proximal left anterior descending artery. The
stent was deployed by inflating the balloon to nominal pressure
(8 atm) for 1 min with a stent:artery of 1.3:1. Repeat angio-
grams were obtained immediately after stent implantation. All
equipment was removed and the artery and vein were ligated.
Four weeks after the procedure the animals underwent repeat
angiograms in the same orthogonal views as well as IVUS
imaging. After sacrifice, the coronary arteries were perfusion-
fixed for histologic analysis.
IVUS imaging protocol. Studies were performed using a
commercially available system (Cardiovascular Imaging Sys-
tems, Inc., San Jose, CA) which incorporated a single element
beveled 30 MHz transducer mounted on the end of a flexible
shaft and rotated at 1800 rpm within a 3.2Fr short monorail
imaging sheath. Intravascular ultrasound imaging was per-
formed after administration of 0.2 mg intracoronary nitroglyc-
erin. The ultrasound catheter was advanced at least 10 mm
beyond the stent and an imaging run (using automated trans-
ducer pullback at 0.5 mm/s) was performed to a point at least
10 mm proximal to the stent. Motorized transducer pullback
through a stationary imaging sheath permitted the transducer
to move at the same speed as the proximal end of the catheter;
this has been validated in vivo (5). During imaging care was
taken to set the overall gain and the time-gain-compensation
curve to avoid suppressing the echolucent neointimal tissue
present in the near field. Studies were recorded only during
transducer pullback onto 1/2 inch high resolution s-VHS
videotape for off-line analysis.
Quantitative coronary angiography (QCA) analysis. The
QCA was performed by an independent core angiographic
laboratory blinded to the IVUS and histomorphometric re-
sults. Quantitative coronary angiography was performed using
an automated edge detection algorithm (CASS II, Pie Medical
Imaging B.V., The Netherlands). Minimal lumen diameter
(MLD), user-defined reference diameter and percent diameter
stenosis (DS) after stent implantation and on follow-up were
measured from multiple projections and the results from the
“worst” view were recorded. Late lumen loss was calculated as
postintervention minus follow-up MLD. The stented segment
was then divided into seven sections. Minimum lumen cross-
sectional areas (CSA) within each section were compared to
the user-defined reference segment to calculate the distribu-
tion of neointimal tissue over the length of the stent.
Quantitative IVUS analysis. Intravascular ultrasound anal-
ysis was performed by an independent core laboratory blinded
to the QCA and histomorphometric results. Motorized trans-
ducer pullback through a stationary imaging sheath permitted
measurements of stent and lumen CSAs at 1 mm axial
increments throughout the length of the stent. At a pullback
speed of 0.5 mm/s, 1 mm is equivalent to 2 s of videotape. The
stent CSA was measured at the leading edge of the stainless
steel wires. If the neointimal tissue (IH) appeared to encom-
pass the imaging catheter, the lumen CSA was assumed to
be the physical (not acoustical) size of the imaging catheter
(1.0 mm2). The IH CSA was then calculated as stent minus
lumen CSA. Intimal hyperplasia volumes were then calculated
using Simpson’s rule. These methods have been reported
previously and are illustrated in Figure 1 (3,4).
Abbreviations and Acronyms
CSA 5 cross-sectional area
DS 5 diameter stenosis
IH 5 intimal hyperplasia
IVUS 5 intravascular ultrasound
MLD 5 minimum lumen diameter
QCA 5 quantitative coronary angiography
Figure 1. The left-hand panel illustrates
the location of the 15 IVUS image slices
sampled within each Palmaz–Schatz stent.
The middle panel shows a representative
IVUS image slice. This slice is duplicated
and annotated in the right-hand panel,
indicating the stent CSA (outer white cir-
cle) and the lumen CSA (inner white cir-
cle). The IH CSA was calculated as stent
minus lumen CSA.
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Histomorphometric analysis. The perfusion-fixed hearts
were harvested, maintained for 24 h in 10% buffered formalin
and sent to the study pathologist. Then the specimens were
embedded in methyl-methacrylate. Sections were cut with a
low-speed diamond wafer mounted to a Buehler Isomet saw
(Buehler Ltd., Evanston, IL), leaving the stent wires intact in
the cross sections to minimize potential artifacts from removal
of stent wires. Sections 50-m to 100-m thick were obtained at
about 1 mm apart and stained with methylchromatic stain. This
resulted in 15 to 20 cross sections per stent. Measurements
were carried out on each section with the Sigmascan software
(Jandel Scientific, San Rafael, CA) through an optical micro-
scope integrated to a digitizing tablet. Histomorphometric
analysis of each section included the neointimal, stent and
lumen CSA. Using Simpson’s rule, neointimal tissue volume
was calculated for each stent. These measurements were then
compared with IVUS measurements.
Statistical analysis. Statistical analysis was performed us-
ing Statview 4.02 (Abacus Concepts) or SAS (Statistical Anal-
ysis Systems, SAS Institute Inc.). Continuous data were pre-
sented as mean value 6 1 SD. Intravascular ultrasound
histomorphometric and QCA results were compared using
linear regression analysis. The distribution of neointimal tissue
over the length of the stent was determined by analysis of
variance. A value p , 0.05 was considered statistically signifi-
cant.
For each stent, five segments were identified and assigned
to one of these categories: 1) distal edge, 2) distal body, 3)
central articulation, 4) proximal body, 5) proximal edge. For
each slice, the stent and lumen CSA was measured and
neointimal tissue calculated (IH 5 stent-lumen CSA). The
stent, lumen and IH CSA for these five slices were then
compared using analysis of variance.
Sample size calculations were performed using the mean
and standard deviation values from the entire study population
to show a 25% and 50% reduction in IVUS IH volume,
follow-up % diameter stenosis, late lumen loss, binary reste-
nosis rate, alpha 5 0.05 and 90% power (6).
Results
Histomorphometric results. At follow-up, IH volume mea-
sured 26.7 6 8.5 mm3 by histomorphometry. Intimal hyperpla-
sia was concentric and distributed uniformly over the length of
the stent (Fig. 2). In 5 of 16 stents, the mean neointimal
thickness was #0.2 mm.
QCA results. By angiography, there was lumen narrowing
throughout the stent. However, in all cases there was a focal
region within the stented segment with smallest lumen, which
was recorded as the minimum lumen diameter.
After stent implantation, reference vessel size was 2.66 6
0.25 mm, MLD was 2.71 6 0.29 mm and DS was 22.3 6
11.5%. At follow-up, reference vessel size was 2.52 6 0.30 mm,
the mean MLD was 1.68 6 0.53 mm, the mean lumen diameter
was 2.34 6 0.16 mm, the maximum lumen diameter was 2.63 6
0.72 mm, and %DS was 30.3 6 11.9%. Late lumen loss was
measured as 1.03 6 0.66 mm. Binary restenosis rate was 20%.
Using the QCA measurement of follow-up %DS, sample size
calculations showed that 15 stented lesions/arm would be
required to show a 50% reduction in follow-up %DS; 52
stented lesions/arm would be required to show a 25% reduc-
tion in follow-up %DS. Using measurement of late lumen loss,
35 stented lesions/arm would be required to show a 50%
reduction in late lumen loss; 139 stented lesions/arm would be
required to show a 25% reduction in late lumen loss. Con-
versely, 266 stented lesions/arm would be required to show a
50% reduction in binary restenosis rate; 1,212 stented lesions/
arm would be required to show a 25% reduction in binary
restenosis rate.
IVUS results. Like the histomorphometric findings, IH was
concentric and distributed uniformly over the length of the
stent (Fig. 2). Intimal hyperplasia volume measured 30.4 6
11.0 mm3 by IVUS and correlated strongly with histomor-
phometry (r 5 0.965, p , 0.0001, Fig. 3). The regression line
was IVUS 5 1.3 3 histomorphometry 23.0. Intravascular
ultrasound detected all five cases with a mean histomorpho-
metric IH thickness #0.2 mm.
The difference between the IVUS and the histomorphomet-
ric measurements of IVUS volume was 4.1 6 2.7 mm3 or
15.8 6 11% (standard error of the estimate 5 0.7). The Bland
and Altman plot of this difference is shown in Figure 3. In all
but one case, the IVUS measurement of IH volume was
greater than histopathology. Table 1 shows the mean and
maximum lumen and stent diameters as measured by QCA,
IVUS and histology within stented segments.
Using the IVUS measurement of IH volume, sample size
calculations showed that 12 stented lesions/arm would be
required to show a 50% reduction in IVUS-measured IH
volume; 44 stented lesions/arm would be required to show a
25% reduction in IVUS-measured IH volume. Compared to
QCA-based sample size calculations of follow-up %DS, late
lumen loss and binary restenosis rate, sample size calculations
Figure 2. The distribution of IH CSA (millimeter squared) measured
by IVUS (left-hand panel) and histopathology (right-hand panel) over
the length of the stent is shown. Each stent is represented by 15 IVUS
and histomorphometric measurements. The proximal end of the stent
is on the left (beginning with slice #1 for IVUS and histomorphom-
etry).
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based on IVUS measurements require a fewer number of
stented lesions.
Discussion
The current study 1) validated the IVUS measurement of
in-stent IH volumes by histomorphometry and 2) showed that
in using volumetric IVUS methodology, only very small sample
sizes should be necessary to show a significant reduction in
in-stent neointimal tissue accumulation.
Previous studies have compared IVUS measurements of
lumen, plaque plus media and external elastic membrane with
histology. These studies have shown good correlation and are
summarized in Table 2. However, these IVUS studies were all
performed in vitro, not in vivo in a beating heart in a moving
blood field; and none studied in-stent neointimal tissue per se.
The current study validated the in vivo IVUS measurement of
in-stent neointimal tissue by histology.
A number of ongoing multicenter trials are assessing strat-
egies to reduce in-stent restenosis. Two of them, ERASER
(Evaluation of Reopro And Stents to Eliminate Restenosis)
and HIPS (Heparin Infusion Prior to Stenting), have been
powered using IVUS measurements of IH volumes as the
primary end point. The current study validates this approach.
In the recently completed SCRIPPS (Scripps Coronary Radi-
ation to Inhibit Proliferation Post Stenting) Trial, IVUS volu-
metric analysis showed a 65% reduction in IH volume in 18
stented lesions/arm (radiation vs. placebo, p 5 0.0091) (7).
Conversely, STRESS (STent REStenosis Study) required 410
patients and BENESTENT (BElgium-NEtherlands STENT
Investigators) required 520 patients to demonstrate the efficacy
of stent implantation in reducing restenosis by QCA (1,2).
Although incorporation of IVUS increases the cost of
restenosis studies, this cost should be offset by the significant
reduction in sample sizes needed to show a treatment effect.
Serial (postintervention and follow-up) IVUS studies have
shown 1) stents do not recoil over time and 2) acute tissue
prolapse (typically through the central articulation of Palmaz–
Schatz stents at the time of implantation) contributes little to
overall neointimal tissue volume (at the time of follow-up) (4).
It will be necessary to perform both postintervention and
follow-up IVUS imaging in assessing strategies to treat in-stent
restenosis. Intravascular ultrasound studies have shown that
significant residual neointimal tissue remains after the treat-
ment of in-stent restenosis whether in-stent restenosis is
treated with balloon angioplasty or atheroablative techniques
(8,9). Thus, in assessing the effects of treatment on previously
stented lesions, paired postintervention and follow-up IVUS
imaging will be necessary. This would obviously double the cost
of both the procedure and of the analysis.
Technical considerations. Neointimal tissue is typically
echolucent. Therefore, neointimal tissue may be more easily
missed (or suppressed) than echo-dense structures such as
stainless steel stent wires. To study the process of in-stent
restenosis, it is important to optimize machine settings to avoid
suppressing the nearfield echoes. Specifically, in the current
study the overall gain and time-gain-compensation curves were
set so that spontaneous blood echoes were visible in the lumen
and so that the leading edge of the neointima was distinct.
Because metal is echoreflective, the stent served as both
an ultrasonic and a histologic marker for the lesion. This
facilitated the comparison of the IVUS images obtained in
vivo, with the subsequent histomorphometric analysis per-
formed ex vivo. Similar in vivo validation studies in nonstented
lesions would be more difficult because of the lack of distinct
ultrasound/histologic markers.
Limitations. Neointimal tissue accumulation and sample
size calculations performed in animal preparations may be
different compared to humans. However, the mean IH volume
in the current study (30 mm3/Palmaz–Schatz stent) was similar
to that reported in placebo groups in one human trial (7) as
Figure 3. The left-hand panel shows the correlation be-
tween the IVUS and histomorphometric measurements of
IH volumes (IVUS 5 1.3 3 histomorphometry 23.0, r 5
0.965, p , 0.0001). The right-hand panel shows the Bland
and Altmann plot of IVUS-histomorphometric measure-
ment of IH volumes. In all but one case, the IVUS
measurement of IH volume was greater than histopathol-
ogy.
Table 1. Mean and Maximum Lumen and Stent Measurements by
QCA, IVUS and Histology
QCA IVUS Histology
Mean lumen diameter (mm) 2.34 6 0.16 2.27 6 0.51 2.01 6 0.27
Maximum lumen diameter (mm) 2.63 6 0.72 2.66 6 0.21 2.35 6 0.30
Mean stent diameter (mm) *NA 2.98 6 0.52 2.36 6 0.11
Maximum stent diameter (mm) *NA 3.24 6 0.14 2.68 6 0.11
*Stent measurements were not performed by QCA as the radiolucent stent
was not well visualized. IVUS 5 intravascular ultrasound; QCA 5 quantitative
coronary angiography.
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well as in a series of 26 consecutive lesions treated with single
Palmaz–Schatz stents and imaged with serial IVUS (10).
Similarly, sample size calculations based on one stent per
lesion may be different when studying lesions treated with
more than one stent. Multiple stents will result in more
neointimal tissue per lesion (4). However, in the SCRIPPS
Trial, there were an average of 1.5 stents/lesion; and despite
the small number of patients, IVUS analysis showed a signif-
icant treatment effect (7).
Despite the excellent correlation (r 5 0.965), IVUS mea-
surement of IH volumes was larger than histomorphometry in
all but one case. This tendency has been reported by others
(11–13). In one previous study of directional coronary atherec-
tomy in vitro, IVUS measurement of retrieved plaque volume
was larger than that measured by histomorphometry but
similar to tissue volume measured by water displacement (11).
It is difficult to avoid completely distortion and shrinkage of
the stented lesion during preparation for histomorphometric
analysis. This could have accounted for the consistent differ-
ence between histologic and IVUS measurements of IH vol-
ume.
The current study measured image slices at 1-mm intervals.
In this porcine coronary in-stent restenosis model, neointimal
tissue was distributed uniformly over the length of the stent.
However, in humans there may be a greater variation in the
patterns of neointimal tissue accumulation (focal vs. diffuse,
central vs. marginal focal, etc.). Thus, an analysis of 15
slices/15-mm long stent may undersample the variation in
neointimal tissue in humans; and sample size calculations may
also differ. An alternative approach would be the use of
computerized automatic contour detection; such a system,
which is already in clinical use, can sample 200 images/lesion
(14–16). However, the current methodology (of 1-mm slices)
has been used in one multicenter trial (7).
Sampling frequency may be dependent on vessel size. At or
beyond the focal zone of the imaging catheters used in the
current study, the beam may spread to 300 to 700 m, limiting
the ability to have independent samples.
Angiography cannot detect radiolucent stents. Therefore,
the used-defined reference lumen CSA was used as a surrogate
of stent area to calculate IH area and distribution.
Conclusion. Intravascular ultrasound measurements of
neointimal hyperplasia volumes correlate well with histomor-
phometry. These measurements are valid for assessing strate-
gies to reduce in-stent neointimal tissue accumulation and
in-stent restenosis.
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